TED P KEMP

Allopathic & Osteopathic Physicians|Internal Medicine DENHAM SPRINGS, LA NPI 1821094574

General Payments — all program years on this page

$1,524.27

  • Category: General Payments
  • Program years: PY2018–2021
  • Record count: 108
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $306.02 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $306.0217

By paying entity

Latest program year (PY2021) · sorted by reported total.

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $115.736
PFIZER INC. $63.664
Novo Nordisk AS $35.082
GlaxoSmithKline, LLC. $34.412
ABBVIE INC. $24.111
Lilly USA, LLC $20.001
Acerta Pharma LLC $13.031

By program year

Program yearAmountRecords
2018 $475.5039
2019 $329.2126
2020 $413.5426
2021 $306.0217

Records — PY2021 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
763466564 Boehringer Ingelheim Pharmaceuticals, Inc. $12.56 06/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
763466566 Boehringer Ingelheim Pharmaceuticals, Inc. $20.00 05/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
763466568 Boehringer Ingelheim Pharmaceuticals, Inc. $23.47 04/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
763466570 Boehringer Ingelheim Pharmaceuticals, Inc. $25.10 03/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
763466572 Boehringer Ingelheim Pharmaceuticals, Inc. $14.78 02/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
763466574 Boehringer Ingelheim Pharmaceuticals, Inc. $19.82 01/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795066097 AbbVie Inc. $24.11 03/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
801714681 GlaxoSmithKline, LLC. $17.89 03/31/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802927635 GlaxoSmithKline, LLC. $16.52 02/09/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811381675 Novo Nordisk Inc $18.88 02/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811655555 Novo Nordisk Inc $16.20 06/29/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
818744045 Lilly USA, LLC $20.00 01/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829390693 AstraZeneca Pharmaceuticals LP $13.03 04/14/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832549487 PFIZER INC. $25.00 04/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
832629277 PFIZER INC. $13.51 01/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833443527 PFIZER INC. $13.27 06/22/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
833485501 PFIZER INC. $11.88 03/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.